Abstract
Our understanding of the antigenic evolution of the human influenza virus is chiefly derived from experiments in which serum from influenza infected ferrets is tested against panels of virus isolates in the haemagglutination inhibition (HI) assay. The interpretation of these results has been much aided by the development of antigenic mapping techniques, which suppose that the antigenic distance between two different influenza viruses is directly proportional to their fold-difference in titre in this assay. Yet, antigenic distance is not necessarily the same as cross-protection, and high levels of protection have been observed in humans against strains to which they have low HI titres. However, no study has previously addressed the relationship between HI titre and cross-protection in ferrets: the standard animal model. This study fills this gap by analysing published data where pre-challenge HI titres are available for individual ferrets, and post-challenge outcomes have been recorded. Ultimately, this work confirms that it is the absolute, rather than relative, HI titre that determines the extent of immunity and that there is a threshold HI titre beyond which ferrets are completely protected from infection. Nevertheless, this ...Continue Reading
References
Dec 1, 1972·The Journal of Hygiene·D HobsonA Ward-Gardner
Mar 1, 1973·The Journal of Hygiene·C W PotterS L Shore
Feb 1, 1974·The Journal of Hygiene·C McLaren, C W Potter
Jun 26, 2004·Science·Derek J SmithRon A M Fouchier
Sep 15, 2005·Statistics in Medicine·Andrew J Dunning
Apr 7, 2007·Vaccine·Iain StephensonJacqueline M Katz
Sep 16, 2009·Emerging Infectious Diseases·Iain StephensonJohn M Wood
Mar 10, 2010·BMC Medical Research Methodology·Laurent CoudevilleRené Ecochard
Aug 19, 2010·The Journal of Infectious Diseases·Karen L LaurieIan G Barr
Jun 23, 2011·Expert Review of Anti-infective Therapy·Jacqueline M KatzXiyan Xu
Oct 29, 2011·The Lancet Infectious Diseases·Michael T OsterholmEdward A Belongia
Nov 22, 2011·Vaccine·John M WoodMaria C Zambon
Sep 7, 2012·PloS One·Kim L RobertsWendy S Barclay
Dec 29, 2012·PLoS Pathogens·Simon CauchemezNeil M Ferguson
Feb 6, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Paul S WikramaratnaSunetra Gupta
Jul 17, 2013·The Journal of Experimental Medicine·Yang LiScott E Hensley
Feb 6, 2014·ELife·Trevor BedfordAndrew Rambaut
Mar 29, 2014·The Journal of Infectious Diseases·Tim K TsangBenjamin J Cowling
Aug 12, 2014·Current Opinion in Virology·Scott E Hensley
Oct 2, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Huong Q McLeanEdward A Belongia
Oct 22, 2014·Proceedings of the National Academy of Sciences of the United States of America·Susanne L LindermanScott E Hensley
May 7, 2015·The Journal of Infectious Diseases·Karen L LaurieIan G Barr
Citations
Apr 19, 2015·Microbiology·Bernard J WolffJonas M Winchell
Mar 4, 2017·PloS One·Jin Il KimMan-Seong Park
Feb 7, 2018·Virus Evolution·Veronika BoskovaCarsten Magnus
Jan 11, 2018·Systematic Biology·Rupert A Collins, Tomas Hrbek
Aug 17, 2018·PLoS Computational Biology·Robert C CopeLewis Mitchell
Jun 5, 2020·Microbial Genomics·Lu Ya Ruth WangVictor P J Gannon
Dec 15, 2018·European Journal of Immunology·Emily GageRhea N Coler